Alkenyl substituted 2,5-piperazinediones, compositions, and uses thereof
Provided herein are compounds of Formula (I), and salts thereof, wherein each instance of R L is independently optionally substituted C 6 -C 40 alkenyl. Further provided are compositions comprising a compound of Formula (I) and an agent. Further provided are methods and kits using the compositions for delivering an agent to a subject or cell and for treating and/or preventing a range of diseases. Further provided are methods of preparing compounds of Formula (I) and precursors thereof.
1. A composition comprising a compound of Formula (I):
or a salt thereof, wherein each instance of R L is independently optionally substituted C 6 -C 40 alkenyl comprising only cis double bonds; a polynucleotide; a PEGylated lipid; a phospholipid; and cholesterol.
2. The composition of claim 1 , wherein the polynucleotide is RNA.
3. The composition of claim 2 , wherein the RNA is messenger RNA, single-stranded RNA, double-stranded RNA, small interfering RNA, precursor messenger RNA, small hairpin RNA, microRNA, guide RNA, transfer RNA, antisense RNA, heterogeneous nuclear RNA, coding RNA, non-coding RNA, long non-coding RNA, satellite RNA, viral satellite RNA, signal recognition particle RNA, small cytoplasmic RNA, small nuclear RNA, ribosomal RNA, Piwi-interacting RNA, polyinosinic acid, ribozyme, flexizyme, small nucleolar RNA, spliced leader RNA, viral RNA, or viral satellite RNA.
4. The composition of claim 2 , wherein the RNA is messenger RNA.
5. The composition of claim 1 , wherein the polynucleotide is DNA.
6. The composition of claim 5 , wherein the DNA is plasmid DNA (pDNA), single-stranded DNA (ssDNA), double-stranded DNA (dsDNA), genomic DNA (gDNA), complementary DNA (cDNA), antisense DNA, chloroplast DNA (ctDNA or cpDNA), microsatellite DNA, mitochondrial DNA (mtDNA or mDNA), kinetoplast DNA (kDNA), provirus, lysogen, repetitive DNA, satellite DNA, or viral DNA.
7. The composition of claim 1 , wherein the polynucleotide encodes a protein or peptide.
8. The composition of claim 7 , wherein the protein or peptide is an antigenic protein or peptide.
9. The composition of claim 8 , wherein the antigenic protein or peptide is an antigen of a virus.
10. The composition of claim 9 , wherein the virus is selected from influenza A, influenza B, and respiratory syncytial virus.
11. The composition of claim 1 , wherein the polynucleotide comprises regulatory regions to control the expression of a gene.
12. The composition of claim 1 , wherein the PEGylated lipid is PEGylated cholesterol, 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)-2000] (C14-PEG 2000), N-octanoyl-sphingosine-1-[succinyl(methoxy polyethylene glycol)-2000], or dimyristoylglycerol (DMG)-PEG-2K.
13. The composition of claim 1 , wherein the PEGylated lipid comprises a poly(ethylene) glycol chain of up to 5 kDa in length covalently attached to a lipid with alkyl chain(s) of C 6 -C 20 length.
14. The composition of claim 1 , wherein the phospholipid is 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), dioleoylphosphatidylcholine (DOPC), dipalmitoylphosphatidylcholine (DPPC), dioleoylphosphatidylglycerol (DOPG), dipalmitoylphosphatidylglycerol (DPPG), dioleoylphosphatidylethanolamine (DOPE), palmitoyloleoylphosphatidylcholine (POPC), palmitoyloleoyl-phosphatidylethanolamine (POPE), dioleoyl-phosphatidylethanolamine 4-(N-maleimidomethyl)-cyclohexane-1-carboxylate (DOPE-mal), dipalmitoyl phosphatidyl ethanolamine (DPPE), dimyristoylphosphoethanolamine (DMPE), distearoyl-phosphatidyl-ethanolamine (DSPE), 16-O-monomethyl PE, 16-O-dimethyl PE, 18-1-trans PE, or 1-stearoyl-2-oleoyl-phosphatidylethanolamine (SOPE).
15. The composition of claim 1 , wherein the composition further comprises 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), cholesterol, and C14-PEG-2000.
16. The composition of claim 1 , wherein at least one instance of R L is a group of formula:
wherein:
x is an integer between 4 and 20, inclusive;
y is an integer between 1 and 20, inclusive;
each instance of z1 and z2 is independently 1, 2, or 3; and
each instance of R′ is independently hydrogen, optionally substituted C 1-6 alkyl, halogen, substituted hydroxyl, substituted thiol, or substituted amino;
provided the group comprises no more than 40 linear carbon atoms.
17. The composition of claim 1 , wherein at least one instance of R L is:
18. The composition of claim 1 , wherein the compound of formula (I) is selected from:
and salts thereof.
19. The composition of claim 1 , wherein the compound of formula (I) has the structure:
or a salt thereof, the polynucleotide is RNA, and the composition further comprises 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), cholesterol, and C14-PEG-2000.
20. The composition of claim 19 , wherein the RNA is messenger RNA.
21. The composition of claim 1 , wherein the compound of formula (I) has the structure:
or a salt thereof, the polynucleotide is RNA, and the composition further comprises 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), cholesterol, and C14-PEG-2000.
22. The composition of claim 21 , wherein the RNA is messenger RNA.
23. The composition of claim 1 , wherein the compound of formula (I) has the structure:
or a salt thereof, the polynucleotide is RNA, and the composition further comprises 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), cholesterol, and C14-PEG-2000.
24. The composition of claim 23 , wherein the RNA is messenger RNA.
25. The composition of claim 1 , wherein the composition is in the form of a particle, micelle, or liposome.
26. The composition of claim 25 , wherein the particle is a microparticle or nanoparticle.
27. The composition of claim 1 , wherein the composition further comprises 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), cholesterol, and C14-PEG-2000.
28. The composition of claim 27 , wherein the RNA is messenger RNA.
29. The composition of claim 1 , wherein the compound of formula (I) has the structure:
or a salt thereof, the polynucleotide is RNA, and the composition further comprises 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), cholesterol, and C14-PEG-2000.
30. The composition of claim 29 , wherein the RNA is messenger RNA.
31. The composition of claim 1 , wherein the compound of formula (I) has the structure:
or a salt thereof, the polynucleotide is RNA, and the composition further comprises 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), cholesterol, and C14-PEG-2000.
32. The composition of claim 31 , wherein the RNA is messenger RNA.
33. The composition of claim 1 , wherein the compound of formula (I) has the structure:
or a salt thereof, the polynucleotide is RNA, and the composition further comprises 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), cholesterol, and C14-PEG-2000.
34. The composition of claim 33 , wherein the RNA is messenger RNA.
35. The composition of claim 1 , wherein the polynucleotide is chemically modified.
36. The composition of claim 1 , wherein the polynucleotide is capable of fixing an error in the genome of a cell or a subject.
37. The composition of 1 , wherein the composition induces an immunologic response upon delivery to a subject.